摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-methyl-2-(4-methylpent-3-enyl)chroman-6-ol | 97530-64-8

中文名称
——
中文别名
——
英文名称
2-methyl-2-(4-methylpent-3-enyl)chroman-6-ol
英文别名
2-methyl-2-(4-methylpent-3-enyl)-3,4-dihydrochromen-6-ol
2-methyl-2-(4-methylpent-3-enyl)chroman-6-ol化学式
CAS
97530-64-8
化学式
C16H22O2
mdl
——
分子量
246.349
InChiKey
DQTRQLFOZHHUHJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    374.0±31.0 °C(Predicted)
  • 密度:
    1.021±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    29.5
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    乙酸酐2-methyl-2-(4-methylpent-3-enyl)chroman-6-ol吡啶 作用下, 反应 16.0h, 生成
    参考文献:
    名称:
    裸枝bra软体动物的化学防御:来自多枝裸裸枝udi的类萜的萜类化合物的结构,生物合成来源和防御特性
    摘要:
    Nudibranch软体动物显然对潜在的掠食者没有防御能力,其次生代谢产物位于体壁上,有助于它们逃避捕食。这些代谢物主要来自饮食。在一个案例中,裸露的分支具有阐述其自身化学防御能力的生物合成能力。
    DOI:
    10.1016/s0040-4020(01)96477-4
  • 作为产物:
    描述:
    6-甲基-5-庚烯-2-酮四氢吡咯咪唑 、 lithium aluminium tetrahydride 、 3 A molecular sieve 、 四丁基氟化铵lithium 作用下, 以 四氢呋喃乙醇N,N-二甲基甲酰胺 为溶剂, 反应 20.17h, 生成 2-methyl-2-(4-methylpent-3-enyl)chroman-6-ol
    参考文献:
    名称:
    Pearce; Parker; Deason, Journal of Medicinal Chemistry, 1994, vol. 37, # 4, p. 526 - 541
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Synthesis of Natural Geranylhydroquinone Analogs
    作者:I. Yu. Chukicheva、I. V. Fedorova、A. A. Koroleva、A. V. Kuchin
    DOI:10.1007/s10600-015-1490-6
    日期:2015.11
    Hydroquinone was alkylated by geraniol in the presence of aluminum-phenoxide and -isopropoxide catalysts. The reaction products were isolated and characterized. Several features of the process were determined.
    对苯二酚苯氧化铝异丙醇催化剂存在下被香叶醇烷基化。分离并鉴定了反应产物。确定了该过程的几个特征。
  • Polybutadiene composition
    申请人:——
    公开号:US20030153655A1
    公开(公告)日:2003-08-14
    There are disclosed a polybutadiene composition comprising: a polybutadiene type polymer, and at least one compound selected from a compound of formula (I-1): 1 or a compound of formula (1-2): 2 wherein R 11 to R 28 are the same or different and independently represent a hydrogen atom, an alkyl group, or the like; or a compound of formula (II): 3 wherein R 1 to R 10 independently represent a hydrogen atom, an alkyl group, or the like; or a styrene-butadiene copolymer, and a benzoin compound; and an article molded therefrom, and processes for producing the composition and the molded article.
    公开了一种聚丁二烯组合物,其中包括 聚丁二烯类聚合物,以及 至少一种选自以下物质的化合物 式(I-1)化合物: 1 或式(1-2)化合物: 2 其中 R 11 至 R 28 相同或不同,且各自代表氢原子、烷基或类似物;或 式 (II) 的化合物: 3 其中 R 1 至 R 10 分别代表氢原子、烷基或类似物;或 苯乙烯-丁二烯共聚物和安息香化合物;以及由其模塑的制品,以及生产该组合物和模塑制品的工艺。
  • Redox Inactivation of Human 15-Lipoxygenase by Marine-Derived Meroditerpenes and Synthetic Chromanes:  Archetypes for a Unique Class of Selective and Recyclable Inhibitors
    作者:Robert H. Cichewicz、Victor A. Kenyon、Stephanie Whitman、Nancy M. Morales、Joanne F. Arguello、Theodore R. Holman、Phillip Crews
    DOI:10.1021/ja046082z
    日期:2004.11.1
    The selective inhibition of human 15-lipoxygenase (15-hLO) could serve as a promising therapeutic target for the prevention of atherosclerosis. A screening of marine sponges revealed that crude extracts of Psammocinia sp. exhibited potent 15-hLO inhibitory activity. Bioassay-guided fractionation led to the isolation of chromarols A-E (8-12) as potent and selective inhibitors of 15-hLO. An additional 22 structurally related compounds, including meroditerpenes from the same Psammocinia sp. (3, 4, 13-16) and our pure compound repository (17, 18), commercially available tocopherols (19-24), and synthetic chromanes (25-32), were evaluated for their ability to inhibit human lipoxygenases. The 6-hydroxychromane moiety found in chromarols A-D was identified as essential for the selective redox inhibition of 15-hLO. Furthermore, the oxidized form of the 6-hydroxychromane could be reduced by ascorbate, suggesting a potential regeneration pathway for these inhibitors in the body. This pharmacophore represents a promising paradigm for the development of a unique class of recyclable 15-hLO redox inhibitors for the treatment of atherosclerosis.
  • US6465548B1
    申请人:——
    公开号:US6465548B1
    公开(公告)日:2002-10-15
  • US6756432B2
    申请人:——
    公开号:US6756432B2
    公开(公告)日:2004-06-29
查看更多